Relmada Therapeutics, Inc. (RLMD)
4.44
+0.02
(+0.45%)
USD |
NASDAQ |
Dec 11, 11:08
Relmada Therapeutics Price: 4.44 for Dec. 11, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Puma Biotechnology, Inc. | 5.65 |
| Sensus Healthcare, Inc. | 3.91 |
| NovaBay Pharmaceuticals, Inc. | 2.655 |
| Palatin Technologies, Inc. | 26.40 |
| Theriva Biologics, Inc. | 0.2269 |
Price Related Metrics
| Price to Book Value | 34.40 |
| Earnings Yield | -40.47% |
| Market Cap | 325.60M |